McKesson and Cardinal Health Extend CVS Drug Supply Deals Through 2032
BofA kept Buy ratings, calling the news a clearing event.
BofA kept Buy ratings, calling the news a clearing event.
Cardinal Health increases annual profit forecast to $9.65-$9.85 per share after exceeding Q1 expectations, driven by specialty medicines and branded drug demand.